ARROWHEAD PHARMACEUTICALS, INC. - 10-Q Filing
Arrowhead Pharmaceuticals filed a 10-Q to report its financial results for the quarter ended March 31, 2026. The filing includes details on revenue, expenses, and financial position, along with updates on collaboration agreements with companies such as GSK, Sarepta, Novartis, and Sanofi. The company also disclosed equity incentive plans and a public offering of pre-funded warrants.
Tickers: $ARWR